antibody therapy
| 4 min read
Two year trial results position Gazyva as a potential first approved therapy for an autoimmune kidney disease with longstanding unmet need.
| 4 min read
Early functional testing could transform the future of antibody-based therapies — here’s how.
| 4 min read
Data-led engineering and platform strategies are transforming T cell engagers into scalable, clinically viable cancer therapies.
Page 1 of 1 - 3 Total Items
